Vasopressin and methylprednisolone for in-hospital cardiac arrest — Protocol for a randomized, double-blind, placebo-controlled trial

Objective: To describe the clinical trial “Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest” (VAM-IHCA). Methods: The VAM-IHCA trial is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of vasopressin and methylpr...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lars W. Andersen, Birthe Sindberg, Mathias Holmberg, Dan Isbye, Jesper Kjærgaard, Stine T. Zwisler, Søren Darling, Jacob Moesgaard Larsen, Bodil S. Rasmussen, Bo Løfgren, Kasper Glerup Lauridsen, Kim B. Pælestik, Christoffer Sølling, Anders G. Kjærgaard, Dorte Due-Rasmussen, Fredrik Folke, Mette Gitz Charlot, Kasper Iversen, Martin Schultz, Sebastian Wiberg, Rikke Malene H.G. Jepsen, Tobias Kurth, Michael Donnino, Hans Kirkegaard, Asger Granfeldt
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2021-03-01
Serie:	Resuscitation Plus
Soggetti:	In-hospital cardiac arrest Vasopressin Methylprednisolone Randomized trial
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2666520421000060
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!